Stock Events

Stock Events

Geovax Labs 

$0.4831
134
-$0.02-4.71% Friday 20:00
+$0.02+3.48%Friday 23:19After hours

Statistics

Day High
0.4863
Day Low
0.4862
52W High
18.67
52W Low
0.483
Volume
2,277
Avg. Volume
-
Mkt Cap
2.52M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

5NovExpected
Q2 2024
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Q2 2026
Next
-7.75
-5.17
-2.58
-0
Expected EPS
-1.09
Actual EPS
N/A

Financials

-862.39%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
2.49MRevenue
-21.47MNet Income

Analyst Ratings

1.00Average Price Target
The highest estimate is 1.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
0%
Hold
100%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow GOVX. It's not an investment recommendation.
NVIDIA
31
NVDA
Amazon
23
AMZN
Tesla
21
TSLA
Palantir Technologies
21
PLTR

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novavax
NVAX
Mkt Cap1.53B
Novavax is a direct competitor in the development of vaccines for infectious diseases, similar to GeoVax's focus area.
Moderna
MRNA
Mkt Cap55.09B
Moderna is involved in mRNA-based vaccines, competing in the same space as GeoVax with its focus on innovative vaccine technologies.
BioNTech
BNTX
Mkt Cap25.64B
BioNTech competes with GeoVax in the development of vaccines for infectious diseases, including COVID-19, leveraging mRNA technology.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson, through its Janssen Pharmaceuticals division, competes in the vaccine market, including efforts against diseases targeted by GeoVax.
Pfizer
PFE
Mkt Cap159.36B
Pfizer, with its global presence and vaccine portfolio, including a COVID-19 vaccine developed with BioNTech, is a competitor in the vaccine space.
Inovio Pharmaceuticals
INO
Mkt Cap133.38M
Inovio Pharmaceuticals focuses on DNA medicines, including vaccines for infectious diseases, positioning it as a competitor to GeoVax.
GSK
GSK
Mkt Cap101.78B
GlaxoSmithKline, with a broad portfolio of vaccines, competes in the same market as GeoVax, targeting various infectious diseases.
Sanofi
SNY
Mkt Cap107.39B
Sanofi, through its vaccine division Sanofi Pasteur, is a major player in the vaccine market, competing with GeoVax in several areas.
Arbutus Biopharma
ABUS
Mkt Cap1B
Arbutus Biopharma is involved in the development of therapeutic solutions for infectious diseases, indirectly competing with GeoVax's vaccine development efforts.

About

Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. The company is focused on the advancement of GEO-MVA, a Modified Vaccinia Ankara (MVA) vaccine candidate for mpox, smallpox, and other poxviruses. Its flagship clinical program in oncology is Gedeptin, a novel oncolytic solid tumor gene-directed therapy, which recently completed a multicenter Phase 1/2 clinical trial for head and neck cancers. The company is also developing GEO-CM04S1, a next-generation multi-antigen COVID-19 vaccine, which is currently being evaluated in two Phase 2 clinical trials.
Show more...
CEO
David Alan Dodd
Employees
19
Country
United States
ISIN
US3736787058
WKN
000A401UX

Listings

MU
DE
E8L.MU
STU
DE
E8LA.STU
MU
DE
E8LA.MU
BOATS
BOATS
GOVX.BOATS

0 Comments

Share your thoughts

FAQ

What is Geovax Labs stock price today?▼
The current price of GOVX is $0.48 USD — it has decreased by -4.71% in the past 24 hours. Watch Geovax Labs stock price performance more closely on the chart.
What is Geovax Labs stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Geovax Labs stocks are traded under the ticker GOVX.
Is Geovax Labs stock price growing?▼
GOVX stock has fallen by -33% compared to the previous week, the month change is a -34.89% fall, over the last year Geovax Labs has showed a -97.23% decrease.
What is Geovax Labs market cap?▼
Today Geovax Labs has the market capitalization of 2.52M
When is the next Geovax Labs earnings date?▼
Geovax Labs is going to release the next earnings report on November 05, 2026.
What were Geovax Labs earnings last quarter?▼
GOVX earnings for the last quarter are -0.97 USD per share, whereas the estimation was -1.2 USD resulting in a +19.17% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Geovax Labs revenue for the last year?▼
Geovax Labs revenue for the last year amounts to 2.49M USD.
What is Geovax Labs net income for the last year?▼
GOVX net income for the last year is -21.47M USD.
How many employees does Geovax Labs have?▼
As of September 05, 2026, the company has 19 employees.
In which sector is Geovax Labs located?▼
Geovax Labs operates in the Health & Wellness sector.
When did Geovax Labs complete a stock split?▼
The last stock split for Geovax Labs was on January 12, 2026 with a ratio of 1:25.
Where is Geovax Labs headquartered?▼
Geovax Labs is headquartered in SMYRNA, United States.